Your browser doesn't support javascript.
loading
TCF-1 regulates HIV-specific CD8+ T cell expansion capacity.
Rutishauser, Rachel L; Deguit, Christian Deo T; Hiatt, Joseph; Blaeschke, Franziska; Roth, Theodore L; Wang, Lynn; Raymond, Kyle A; Starke, Carly E; Mudd, Joseph C; Chen, Wenxuan; Smullin, Carolyn; Matus-Nicodemos, Rodrigo; Hoh, Rebecca; Krone, Melissa; Hecht, Frederick M; Pilcher, Christopher D; Martin, Jeffrey N; Koup, Richard A; Douek, Daniel C; Brenchley, Jason M; Sékaly, Rafick-Pierre; Pillai, Satish K; Marson, Alexander; Deeks, Steven G; McCune, Joseph M; Hunt, Peter W.
Afiliação
  • Rutishauser RL; Department of Medicine, UCSF, San Francisco, California, USA.
  • Deguit CDT; Department of Medicine, UCSF, San Francisco, California, USA.
  • Hiatt J; Institute of Human Genetics, University of the Philippines-National Institutes of Health, Manila, Philippines.
  • Blaeschke F; Department of Microbiology and Immunology.
  • Roth TL; Medical Scientist Training Program.
  • Wang L; Biomedical Sciences Graduate Program, and.
  • Raymond KA; Department of Microbiology and Immunology.
  • Starke CE; Diabetes Center, UCSF, San Francisco, California, USA.
  • Mudd JC; Innovative Genomics Institute, University of California, Berkeley, Berkeley, California, USA.
  • Chen W; Department of Microbiology and Immunology.
  • Smullin C; Medical Scientist Training Program.
  • Matus-Nicodemos R; Biomedical Sciences Graduate Program, and.
  • Hoh R; Department of Medicine, UCSF, San Francisco, California, USA.
  • Krone M; Vitalant Research Institute, San Francisco, California, USA.
  • Hecht FM; Department of Laboratory Medicine, UCSF, California, USA.
  • Pilcher CD; Barrier Immunity Section, Laboratory of Viral Diseases and.
  • Martin JN; Barrier Immunity Section, Laboratory of Viral Diseases and.
  • Koup RA; Department of Medicine, UCSF, San Francisco, California, USA.
  • Douek DC; Department of Medicine, UCSF, San Francisco, California, USA.
  • Brenchley JM; Human Immunology Section, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, Maryland, USA.
  • Sékaly RP; Department of Medicine, UCSF, San Francisco, California, USA.
  • Pillai SK; Department of Epidemiology and Biostatistics, UCSF, San Francisco, California, USA.
  • Marson A; Department of Medicine, UCSF, San Francisco, California, USA.
  • Deeks SG; Department of Medicine, UCSF, San Francisco, California, USA.
  • McCune JM; Department of Epidemiology and Biostatistics, UCSF, San Francisco, California, USA.
  • Hunt PW; Immunology Laboratory, Vaccine Research Center, National Institute of Allergy and Infectious Diseases , NIH, Bethesda, Maryland, USA.
JCI Insight ; 6(3)2021 02 08.
Article em En | MEDLINE | ID: mdl-33351785
ABSTRACT
Although many HIV cure strategies seek to expand HIV-specific CD8+ T cells to control the virus, all are likely to fail if cellular exhaustion is not prevented. A loss in stem-like memory properties (i.e., the ability to proliferate and generate secondary effector cells) is a key feature of exhaustion; little is known, however, about how these properties are regulated in human virus-specific CD8+ T cells. We found that virus-specific CD8+ T cells from humans and nonhuman primates naturally controlling HIV/SIV infection express more of the transcription factor TCF-1 than noncontrollers. HIV-specific CD8+ T cell TCF-1 expression correlated with memory marker expression and expansion capacity and declined with antigenic stimulation. CRISPR-Cas9 editing of TCF-1 in human primary T cells demonstrated a direct role in regulating expansion capacity. Collectively, these data suggest that TCF-1 contributes to the regulation of the stem-like memory property of secondary expansion capacity of HIV-specific CD8+ T cells, and they provide a rationale for exploring the enhancement of this pathway in T cell-based therapeutic strategies for HIV.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por HIV / HIV-1 / Linfócitos T CD8-Positivos / Fator 1 de Transcrição de Linfócitos T Limite: Adult / Aged / Animals / Female / Humans / Male / Middle aged Idioma: En Revista: JCI Insight Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por HIV / HIV-1 / Linfócitos T CD8-Positivos / Fator 1 de Transcrição de Linfócitos T Limite: Adult / Aged / Animals / Female / Humans / Male / Middle aged Idioma: En Revista: JCI Insight Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos